## Abstract **Background**: Around 16% of all patients who present with atheromatous renovascular disease (ARVD) in the United States undergo revascularization. Historically, patients with advanced chronic kidney disease (CKD) have been considered least likely to show improvement in renal functiona
Dynamic MRI contrast enhancement of renal cortex: A functional assessment of renovascular disease in patients with renal artery stenosis
✍ Scribed by Stephen J. Gandy; Thiru A.P. Sudarshan; Declan G. Sheppard; Lynsay C. Allan; Trudy B. McLeay; J. Graeme Houston
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 416 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Purpose
To evaluate differences in the magnitude and time course of renal cortical contrast uptake in patients with minimal, moderate, and severe renal artery stenosis (RAS) using contrast‐enhanced magnetic resonance renography (CE‐MRR).
Materials and Methods
CE‐MRR was performed on 56 patients with renovascular disease using a three‐dimensional volume interpolated breath‐hold examination (VIBE) perfusion sequence. After administration of 2 mL of contrast, nine sequential axial VIBE datasets were acquired: at baseline, 7, 14, 21, 45, 60, 120, 180, and 240 seconds. Aortic peak signal enhancement and cortical peak signal enhancement through the mid portion of each kidney was recorded, along with the time delay between each peak. Each renal artery was subsequently examined using three‐dimensional contrast‐enhanced MR angiography, and graded as being minimally (0%–30%), moderately (31%–70%), or severely (71%–100%) stenotic.
Results
When the data were subdivided by RAS category, the cortical to aortic peak enhancement ratio (CAPR) reduced with increasing RAS. Further, the cortical to aortic time delay (CATD) increased with increasing RAS. These measurements were statistically significant between patients with minimal and moderate RAS compared to severe RAS
Conclusion
CE‐MRR can assist in the differentiation of patients with minimal or moderate RAS from those with severe RAS. J. Magn. Reson. Imaging 2003;18:461–466. © 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract ## Purpose To evaluate the current literature to see if the published results of MRI‐glomerular filtration rate (GFR) stand up to the claim that MRI‐GFR may be used in clinical practice. Claims in the current literature that Gadolinium (Gd) DTPA dynamic contrast enhanced (DCE) MRI clea